About M3

M3 is a one of a kind venture company that operates a multitude of global services centred around its physician platform such as m3.com .

M3 is the only company incorporated after the year 2000 to be included in the Nikkei 225 Index. Its 320,000+ Japanese and 6,500,000+ global physician member panel serves as a central platform in advancing innovation and reform across healthcare worldwide.

Philosophy & Approach

“Making use of the Internet to increase, as much as possible, the number of people who can live longer and healthier lives, and to reduce, as much as possible, the amount of unnecessary medical costs”

- this is both the desire and goal of M3.

We strive to innovate the medical industry through provision of quality medical information for the clinical scene.
Our services and products aim to provide our clients and members with never ending inspiration, exhilaration, and joy.
We hope to provide corporate value for our investors, while inviting concordance with our mission to serve society.
It is important to maintain an enriching work environment that promotes rewarding each team member to grow and flourish, and where one can share a unified purpose with the group, whether they be a professional in medicine, IT, communication, management, and others.
Given there is a limit to what we can do as M3, we wish to continue collaborative efforts with like-minds to actualize advancement in the field of medicine.

Overview

Company Name

M3, Inc.

Established

September 2000

Capital

29,192 million yen (as of end of March, 2023)

Listed Exchange

Tokyo Stock Exchange Prime Market (Securities code 2413)

Employees

588 [consoli. 10,533] (as of end of March, 2023)

Head Office

Akasaka Intercity 10th floor
1-11-44 Akasaka
Minato-ku, Tokyo 107-0052 JAPAN
TEL:+81-3-6229-8900 FAX:+81-3-6229-8922

Nature of Business

Providing medical-related services through the use of the Internet.

Directors and Auditors

  • Itaru Tanimura, Representative Director
  • Akihiko Tomaru, Director
  • Eiji Tsuchiya, Director
  • Kazuyuki Izumiya, Director
  • Rie Nakamura, Director
  • Yoshinao Tanaka, Director
  • Satoshi Yamazaki, Director
  • Kenichiro Yoshida, Director
  • Yusuke Tsugawa, Director
  • Mayuka Yamazaki, Director (Audit and Supervisory Committee Member)
  • Takako Ebata, Director (Audit and Supervisory Committee Member)
  • Ryoko Toyama, Director (Audit and Supervisory Committee Member)

M3 Group Code of Conduct

M3 Corporate Governance Report

History

We are promoting various businesses to solve problems in the medical industry.

2000
September

Established the Company

October

Launched the "MR-kun" service

2002
March

Acquired medical information website "WebMD Japan" from WebMD Japan, Inc.

August

Launched the "Research-kun"
survey service Re-named "WebMD Japan" to "So-netm3.com" survey service Re-named "WebMD Japan" to "So-netm3.com"

2003
January

Acquired medical information website "MediPro/MyMediPro" from Sony Communications Network Corporation (currently So-net Entertainment Corporation)

February

Launched "MR-kun eCSO," a pharmaceutical product online promotion service integrated with MR-kun

July

Launched "m3.com", a medical information website composed of merged content from "MyMediPro" and "So-netm3.com"

October

November

2004
April

Launched "m3.com CAREER", a job search service for doctors

September

Listed on Tokyo Stock Exchange Mothers Market (IPO)

2005
June

Alliance with Medi C&C Co., Ltd. (Korea)

September

Listed on Tokyo Stock Exchange Mothers Market (IPO)

December

Launched "AskDoctors", M3's first B-to-C service

2006
June

Acquired MDLinx, Inc. (USA)

2007
March

Listed on Tokyo Stock Exchange First Section (currently the Tokyo Stock Exchange Prime Market)

2008
June

Acquired iTICKET Corporation

2009
March

Merged So-net M3 USA Corporation and MDLinx, Inc.

April

Acquired Mebix, Inc.

December

Established M3 Career, Inc.

2010
January

Changed company name to M3, Inc.

2011
August

Acquired Doctors.net.uk Limited (UK)

2012
August

Acquired MIC Medical Corp. (Japan)

October

Acquired C.M.S Co.Ltd (Japan)

2013
November

Entered into Chinese market

2014
February

Acquired Mediscience Planning Inc. (Japan)

2016
December

Acquired Vidal Group and entered into French, German, and Spanish markets

2017
November

Acquired Cosmotec Co., Ltd. and JAMECS Inc. (Japan)

November

Acquired QQFS, one of the largest physician panel in the Nordic region

2019
March

Acquired DailyRounds, Inc. (India)

2022
April

Moved from the First Section to the Prime Market of the Tokyo Stock Exchange as a result of a revision of the market classification of the Tokyo Stock Exchange